greenshots
Senior Member
- Messages
- 399
- Location
- California
The AHCY is where homocysteine is activated, when its not working, homocysteine levels are lower and it takes the strain off any CBS defects present (which I think you have?). This means, you may not see the same problems on lab tests with CBS defects (high taurine, ammonia may be a little lower, homocysteine could be normal or high normal despite MTHFR C677T, etc.). SAMe is not warranted here but for the record, I have a double CBS 699t and double AHCY and take SAMe. However, I am a COMT -/- so I can tolerate a BUCKET load of these methyl groups. That's about what I know there, sorry I don't have more for you.
Angela
Angela
I'm trying to get my head around the significance of AHCY mutations as I have 1 homozygous and 2 heterozygous! The heartfixer description is really lousy for this mutation.
Is anyone able to confirm if the consequence of AHCY mutations is poor recycling of S-adenosylhomocysteine back to homocysteine resulting in excess SAH and less homocysteine for production of methionine and SAMe?
I suspect there may be a mistake on the heartfixer website the following:
"S-Adenosyl Methionine (SAMe), the key methyl donor generated from methionine, is metabolized in to S-Adenosyl Methionine"
is supposed to be:
"S-Adenosyl Methionine (SAMe), the key methyl donor generated from methionine, is metabolized in to S-Adenosyl Homocysteine"
as it doesn't make sense to metabolize SAMe to SAMe....
Is it also satisfactory to assume that all MTR mutations caused excessive methylb12 degredation and all MTRR mutations result in poor synthesis of methylb12 and this is why heartfixer is grouping them all together?
There's only information out there on a couple of these mutations, not all.